ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

22,109Medicare Part D Prescriptions Filled, Including Refills

Rank: 15 out of 2094

$1.76M Total Retail Price of All Prescriptions

Rank: 17 out of 2094

440 Patients Receiving at Least One Drug in Part D
94%Patients 65 Years and Older
95% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in New Jersey
Lower avg

Schedule Two
Controlled Substances

3% of this provider’s 440 patients filled at least one prescription for a schedule two drug, compared to an average of 6%.

Schedule Three
Controlled Substances

16% of this provider’s 440 patients filled at least one prescription for a schedule three drug, compared to an average of 3%.

Risky Drugs to Seniors

0% of this provider’s 21,704 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

47% of this provider’s prescriptions were for brand-name drugs, compared to an average of 32%.

Prescription Price

$79 was the average price of a prescription from this provider, compared to $78 among peers.

Prescriptions per Patient

50 is the average number of prescriptions (including refills) per patient, compared to an average of 17.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in New Jersey
METOPROLOL SUCCINATE 715 711 1 9
ATORVASTATIN CALCIUM 689 678 2 5
AMLODIPINE BESYLATE 606 590 3 2
CRESTOR 602 602 4 15
LIPITOR 518 511 10 5 39
SIMVASTATIN 477 450 6 1
METFORMIN HCL 461 454 7 8
DIOVAN 460 460 8 13
NEXIUM 455 455 9 16
ZOLPIDEM TARTRATE 403 402 10 14
LEVOXYL 396 388 11 130
PLAVIX 379 377 12 38
CARVEDILOL 379 378 12 19
OMEPRAZOLE 370 370 14 4
LEVOTHYROXINE SODIUM 369 363 15 3
GLIMEPIRIDE 364 358 16 31
PRAVASTATIN SODIUM 353 322 17 18
METOPROLOL TARTRATE 351 326 18 10
DIOVAN HCT 346 346 19 28
TAMSULOSIN HCL 345 341 20 29
CLONIDINE HCL 313 306 21 62
ATENOLOL 310 298 22 21
CLOPIDOGREL 300 294 23 22
NITROGLYCERIN PATCH 290 290 24 101
JANUVIA 288 288 25 35
WARFARIN SODIUM 288 286 25 11
LOSARTAN POTASSIUM 248 241 27 17
LOVAZA 228 228 28 53
LIDODERM 214 214 29 59
AVODART 210 210 30 163
ESCITALOPRAM OXALATE 203 201 31 46
LOSARTAN-HYDROCHLOROTHIAZIDE 200 185 32 52
JANUMET 189 185 33 86
FUROSEMIDE 185 181 34 6
EXFORGE 178 178 35 105
DIGOXIN 176 176 36 51
RAMIPRIL 175 162 37 48
ISOSORBIDE MONONITRATE ER 171 171 38 57
ZETIA 160 160 39 79
CLONIDINE 154 154 40 261
LEXAPRO 150 150 41 180
NAMENDA 147 147 42 32
MELOXICAM 146 143 43 49
DONEPEZIL HCL 145 145 44 20
FINASTERIDE 144 144 45 97
POLYETHYLENE GLYCOL 3350 137 137 46 75
AMLODIPINE BESYLATE-BENAZEPRIL 136 128 47 58
ADVAIR DISKUS 135 133 48 36
NIFEDIPINE ER 133 133 49 96
DOXAZOSIN MESYLATE 131 131 50 120
ALLOPURINOL 128 128 51 50
HYDROCHLOROTHIAZIDE 124 124 52 12
ONGLYZA 121 121 53 134
SERTRALINE HCL 111 109 54 26
VOLTAREN 108 107 55 109
IBANDRONATE SODIUM 106 106 56 140
ACTONEL 103 103 57 151
METFORMIN HCL ER 102 101 58 67
HYDROCODONE-ACETAMINOPHEN 100 96 S3 59 42
POTASSIUM CHLORIDE 99 98 60 24
BENICAR HCT 98 88 61 133
TORSEMIDE 94 91 62 118
NITROSTAT 94 94 62 314
LISINOPRIL 93 85 64 7
SINGULAIR 92 90 65 64
EXFORGE HCT 86 86 66 195
CREON 81 81 67 219
ACETAMINOPHEN-CODEINE 81 79 S3 67 129
ENALAPRIL MALEATE 79 76 69 25
AMIODARONE HCL 79 79 69 175
VYTORIN 78 78 71 162
ATELVIA 77 77 72 135
GABAPENTIN 77 60 72 23
FAMOTIDINE 76 76 74 34
COUMADIN 75 75 75 261
FLUTICASONE PROPIONATE 75 70 75 41
DEXILANT 74 74 77 124
NOVOLOG FLEXPEN 74 71 77 142
PAROXETINE HCL 71 71 79 77
SYNTHROID 69 69 80 44
TRILIPIX 69 69 80 156
COLCRYS 69 69 80 230
MECLIZINE HCL 67 62 83 103
SPIRONOLACTONE 67 67 83 93
NIFEDICAL XL 62 62 85 403
TOPROL XL 59 59 86 227
AVAPRO 58 58 87 491
AZITHROMYCIN 58 55 87 27
CITALOPRAM HBR 58 58 87 47
TRIAMTERENE-HCTZ 56 56 90 87
PRANDIN 55 55 91 125
FEXOFENADINE HCL 55 55 91 191
ZEMPLAR 53 53 93 287
SOLARAZE 52 52 94 278
LEVEMIR FLEXPEN 51 51 95 188
ACTOS 50 50 96 112
KETOCONAZOLE 50 46 96 196
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Sept. 14, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.